FDA sends warning letter over alleged violations at leading device reprocessor Alliance Medical
This article was originally published in Clinica
In the midst of discussions over the regulation of third-party medical device reprocessors, the US FDA has side-stepped its critics by issuing a highly publicised warning letter to industry leader Alliance Medical. The warning letter claimed that agency inspectors uncovered serious problems at the Phoenix, Arizona-based company's decontamination facility in Florida.
You may also be interested in...
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.